Previous studies have confirmed that GBM cells can inhibit the maturation and functioning of immune cells by secreting a variety of cytokines that upregulating immune checkpoint pathways such as programmed cell death protein-1 (PD-1) pathway, which leads to the progression of GBM [41, 42]. This evidence concerns the gene PDCD1 and glioblastoma.